| Organism |
Gene(s) |
Editing |
Reference |
| Mouse |
ASXL1 |
Non sense point mutation |
[87] |
| Mice |
Human ICC/HCC |
Multiplex mutagenesis |
[88] |
| Human |
CFTR |
Homozygous deletion of F508 |
[89] |
| Mouse |
Crygc |
Correction of genetic disease |
[90] |
| Mice |
Dystrophin gene (Dmd) |
Destrophin related duchenne muscular dystrohy |
[91] |
| Human |
Cas9 nuclease and nickase |
Fanconi anemia gene correction |
[92] |
| Mouse |
AAV9 |
Postnatal genome editing |
[93] |
| Mouse |
Fah |
In vivo therapies |
[94] |
| Mouse |
PCSK9 |
Mouse hepatocyte editing |
[95] |
| Mammalian brain |
CHD8 |
Autism spectrum disorder |
[96] [97] |
| Wild mice |
PTEN & TP53 |
Tumor suppressor genes |
[98] [99] [100] |
| Human |
HIV-I |
virus |
[101] - [107] |
| Human |
Burkitt’s Lymphoma cells |
Latent Herpesviridae |
[108] |
| Human |
HPV16-E7 |
Papillomavirus |
[109] |
| Humans |
HBV cccDNA |
Hepatitis-B |
[110] |
| Human |
CXCR4 & CCR5 |
AIDS |
[107] [108] [111] |
| Pig |
PERVs |
Viral disruption |
[112] |
| Human |
Pig Alb locus |
Human Albumin production |
[112] |
| Corn |
LIG1, Ms26 and Ms45, ALS1 and 2 |
Targeted mutagenesis, Precise gene editing, Site specific gene insertion |
[113] |
| Soybean |
DD20 and DD43 |
Genome editing |
[111] |
| Nicotiana benthamiana |
---------- |
Tomato Yellow Leaf Curl Virus |
[114] |
| Mushrooms |
---------- |
CRISPR Edited Mushrooms |
[115] |